GenSight Biologics S.A. (EPA:SIGHT)
France · Delayed Price · Currency is EUR 0.0850
-0.0040 (-4.49%)
May 14, 2026, 5:35 PM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €20.87 million as of May 14, 2026. Its market cap has decreased by -29.79% in one year.
Market Cap
20.87M
Enterprise Value
31.32M
Revenue
652.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.09
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 20.87M, a decrease of -91.72%. That is a compound annual growth rate of -22.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 20.87M | -9.35% |
| Dec 31, 2025 | 23.02M | -30.35% |
| Dec 31, 2024 | 33.05M | 28.79% |
| Dec 29, 2023 | 25.66M | -83.46% |
| Dec 30, 2022 | 155.20M | -39.23% |
| Dec 31, 2021 | 255.38M | -16.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| THX Pharma Société Anonyme | 47.60M |
| Fermentalg | 44.41M |
| Nicox | 33.27M |
| genOway Société anonyme | 22.13M |
| Aelis Farma | 17.32M |
| Poxel | 13.70M |
| Advicenne | 13.37M |
| Aton | 12.75M |